Concepedia

Jörgen Elgqvist

JE

18

Publications

925

Citations

15

H-Index

2003

Active since

Affiliations

University of Gothenburg(Current)

Rigshospitalet

Lund University

Sahlgrenska University Hospital

Chalmers University of Technology

Jörgen Elgqvist is an author at University of Gothenburg specializing in medicine, cancer therapeutics, and radiation oncology.

Top concepts

Publications per year

2003–2019

18

Publications

18

Intraperitoneal α-Particle Radioimmunotherapy of Ovarian Cancer Patients: Pharmacokinetics and Dosimetry of <sup>211</sup>At-MX35 F(ab′)<sub>2</sub>—A Phase I Study

Håkan Andersson, Elin Cederkrantz, Tom Bäck et al. · Journal of Nuclear Medicine · 2009 · 279 citations · Full text

Direct Procedure for the Production of<sup>211</sup>At-Labeled Antibodies with an ε-Lysyl-3-(Trimethylstannyl)Benzamide Immunoconjugate

Sture Lindegren, Sofia H.L. Frost, Tom Bäck et al. · Journal of Nuclear Medicine · 2008 · 78 citations · Full text

Therapeutic Efficacy of Astatine-211–Labeled Trastuzumab on Radioresistant SKOV-3 Tumors in Nude Mice

Stig Palm, Tom Bäck, Ingela Claesson et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 72 citations · Full text

, , +9

Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.

Jörgen Elgqvist, Håkan Andersson, Tom Bäck et al. · PubMed · 2005 · 72 citations

Alpha-radioimmunotherapy of intraperitoneally growing OVCAR-3 tumors of variable dimensions: Outcome related to measured tumor size and mean absorbed dose.

Jörgen Elgqvist, Håkan Andersson, Tom Bäck et al. · PubMed · 2006 · 68 citations

Rows per page

1–5 of 18